TP53 and hepatocellular carcinoma: On the contrary, dual silencing of AXIN1 and TP53, predicted as a non-significant SL pair by SLIdR, did not result in decreased proliferation in HCC cells (Supplementary Fig. 5), thus confirming the specificity of the synthetic lethal interactions predicted by SLIdR.